The certification comes at a time when the nutraceutical industry faces growing scrutiny. Recent reports have exposed serious safety concerns, with nearly 40% of supplements tested in 2023 either failing to meet label claims or containing harmful contaminants. These issues have created a sense of mistrust among consumers and raised concerns about industry accountability.
Denis Đalapa, PharmaLinea’s Technical Director, explained: “Several factors are contributing to the quality challenges in the supplement industry, economic pressure being among the most prominent ones. For certain raw materials, where there’s many suppliers on the market, cost optimization often comes at the expense of quality. During our production processes, the biggest quality issue we’re encountering is with plant extracts, due to their likely exposure to contamination. In some markets, low environmental and regulatory awareness can worsen the issue of substandard production environment, allowing contaminants to enter the supply chain. Additional factors include lack of high-quality raw materials and limited access to advanced testing technologies.”